Context Therapeutics posts results for terminated elacestrant-onapristone breast cancer trialTrial updateContext Therapeutics Inc.elacestrant
Results posted for onapristone-anastrozole trial in refractory endometrial cancerTrial updateanastrozoleContext Therapeutics Inc.
Sign inSign in